A detailed history of Sensible Money, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sensible Money, LLC holds 1,458 shares of ABBV stock, worth $282,152. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,458
Previous 1,458 -0.0%
Holding current value
$282,152
Previous $226 Million 17.51%
% of portfolio
0.14%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jun 25, 2024

SELL
$137.6 - $154.97 $963 - $1,084
-7 Reduced 0.48%
1,458 $226 Million
Q3 2023

Jun 25, 2024

SELL
$133.59 - $154.65 $10,420 - $12,062
-78 Reduced 5.06%
1,465 $218 Million
Q2 2023

Jun 25, 2024

BUY
$132.51 - $164.9 $11,130 - $13,851
84 Added 5.76%
1,543 $208 Million
Q1 2023

Jun 25, 2024

SELL
$144.61 - $166.54 $7,664 - $8,826
-53 Reduced 3.51%
1,459 $233 Million
Q4 2022

Jun 25, 2024

BUY
$138.31 - $165.87 $209,124 - $250,795
1,512 New
1,512 $244 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sensible Money, LLC Portfolio

Follow Sensible Money, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sensible Money, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sensible Money, LLC with notifications on news.